Oncology

Medtech Company Cooler Heads Adds $1.5M in New Funding After Receiving FDA Clearance to Help Save Cancer Patients’ Hair

Medtech company Cooler Heads has announced FDA clearance for its scalp cooling device to help cancer patients undergoing chemotherapy save their hair and adds $1.5M in funding to invest in commercialization. The company participated in Ad Astra’s San Diego-based accelerator program and has raised $3.1M in funding to date from Robin Hood Ventures, Anathem Ventures, Crescent Ridge Partners, Gaingels, Astia Angels, and Teal Ventures,…

Whiterabbit Partners with Solis Mammography to Increase Patient Compliance with Annual Check-ups

Whiterabbit, an AI technology company focused on early breast cancer detection, has announced a new partnership with Solis Mammography, one of the largest independent providers of breast health and diagnostic services in the United States. After pilots in multiple markets demonstrated improvement in screening mammography bookings and patient compliance, the company implemented the ACT product at more than 70 centers. Through this…

Therapixel Receives FDA Clearance for Use of Its AI-based Breast Cancer Screening Software MammoScreen on Digital Breast Tomosynthesis

Therapixel has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MammoScreen, AI-based software assisting radiologists in breast cancer screening. This new clearance expands the use of Mammoscreen to Digital Breast Tomosynthesis (3D Mammography). Therapixel is a French company specialized in the design and commercialization of AI-powered medical imaging software, with the goal of delivering pertinent information…

Novarad and Ikonopedia Partner to Elevate Women’s Health in One Complete Mammography Platform

Medical software provider Novarad has formed a strategic partnership with Ikonopedia, a structured breast reporting and MQSA management system designed to improve reporting efficiency and optimize facility operations. Ikonopedia’s next-generation breast reporting and tracking system for mammography will integrate with Novarad’s NovaMG PRO mammography platform. By combining leading-edge technologies with innovative software applications to connect patient care, Novarad’s complete care platform can…

Bia Care Partners with GenesisCare to Support Women Experiencing Menopause as a Side Effect of Cancer Treatment

Around 30% of women treated for breast cancer will experience the sudden onset of menopause symptoms, as a result of their treatment. Over 200,000 women every year in England will experience this side effect during their cancer care, with no treatment currently offered as standard. If women do not receive support, a quarter will leave employment as a result of their menopause…

Israeli Femtech Company MobileODT Participates In India’s Largest Cervical Cancer Screening Program

MobileODT, an Israeli femtech company innovating in cervical cancer screening, is supporting a national cervical cancer screening project in India. This will be the most comprehensive and largest cervical cancer screening program performed in India, to date. The project will be run by Karkinos Healthcare in strategic collaboration with GenWorks Health, MobileODT’s exclusive distributor in India. The partnership will adopt the World Health Organization’s (WHO) recommended Human Papilloma Virus (HPV)…

New Survey: Women Are Skipping Cancer Screenings During the Pandemic, But Plan to get ‘Back on the Books’

The Prevent Cancer Foundation has released the results of a survey conducted with 2000+ women and people assigned female at birth in the U.S, that shows that women are skipping cancer screenings during the pandemic. 90% of women say when local pandemic restrictions were lifted, they engaged in normal activities, such as visiting family and friends, dining out and shopping, but only 48%…

Fujifilm and ScreenPoint Medical Now Offer Providers an AI Solution Designed for Early Breast Cancer Detection

FUJIFILM, a provider of diagnostic imaging and medical informatics solutions, has announced that its ASPIRE Cristalle mammography system with digital breast tomosynthesis (DBT) now offers ScreenPoint Medical’s new, FDA cleared Transpara powered by Fusion AI for 2D and 3D mammography in the United States. ScreenPoint Medical’s AI solution, coupled with the ASPIRE Cristalle mammography system, displays breast screening findings at a doctor’s reading workstation or PACS…